|
Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
| 56.99 USD | +0.04% |
|
-.--% | - |
| 24-08-16 | Eli Lilly Wraps Up Purchase of Biopharma Group Morphic | MT |
| 24-08-16 | Eli Lilly Completes $3.2 Billion Acquisition of Morphic Holding | MT |
| Market Cap | 2.86B 2.5B 2.31B 2.13B 4.01B 276B 4.1B 27.59B 10.85B 135B 10.75B 10.51B 465B | P/E 2022 |
-17.3x | P/E 2023 | -8.04x |
|---|---|---|---|---|---|
| Enterprise Value | 2.86B 2.5B 2.31B 2.13B 4.01B 276B 4.1B 27.59B 10.85B 135B 10.75B 10.51B 465B | EV / Sales 2022 |
14,564,450x | EV / Sales 2023 | 2,757,343,865x |
| Free-Float |
-
| Yield 2022 * |
-
| Yield 2023 | - |
| 1 day | +0.04% |
| 3 years | 19.34 | 62.08 | |
| 5 years | 19.23 | 68.75 | |
| 10 years | 9.9 | 93 |
| Manager | Title | Age | Since |
|---|---|---|---|
Jonathan Haug
PSD | President | - | - |
Marc Schegerin
DFI | Director of Finance/CFO | 50 | 2020-04-05 |
Simon Cooper
CTO | Chief Tech/Sci/R&D Officer | 57 | 2024-03-18 |
| Director | Title | Age | Since |
|---|---|---|---|
Jonathan Haug
BRD | Director/Board Member | - | - |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 8/16/24 | Issuer sale | Chief Technology Officer | 191,000 | 0.3803% | ||
| 8/16/24 | Tender | Chief Executive Officer | 2,332,585 | 4.6443% | ||
| 8/16/24 | Issuer sale | General Counsel | 561,952 | 1.1189% |
| 2022 | 2023 | |
|---|---|---|
| Net sales | 70.81M 61.88M 57.1M 52.63M 99.2M 6.82B 101M 682M 268M 3.34B 266M 260M 11.5B | 521K 455K 420K 387K 730K 50.17M 746K 5.02M 1.98M 24.57M 1.96M 1.91M 84.59M |
| Net income | -59.04M -51.6M -47.61M -43.89M -82.72M -5.69B -84.55M -569M -224M -2.78B -222M -217M -9.59B | -152M -133M -123M -113M -213M -14.65B -218M -1.47B -577M -7.17B -571M -559M -24.69B |
| Net Debt | -348.25 -304.33 -280.83 -258.86 -487.9 -33.54K -498.73 -3.36K -1.32K -16.42K -1.31K -1.28K -56.54K | -704.35 -615.53 -567.99 -523.55 -986.79 -67.83K -1.01K -6.79K -2.67K -33.22K -2.65K -2.59K -114K |
Employees
128
Sector
-
- Stock Market
- Stocks
- MORF Stock
Select your edition
All financial news and data tailored to specific country editions
















